ADDED
The number of ordinary shares of the Company outstanding as of January 31, 2026 , was 640,698,582 .
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Certain Relationships and Related Transactions, and Director Independence.
Unless otherwise indicated, throughout this annual report, dollar and euro amounts are presented in millions, except for per share amounts.
Our aim is to fuel the world s greatest breakthroughs by harnessing the power of human ingenuity.
From research and learning to commercialization, we offer intelligence solutions, workflow solutions, and tech-enabled services to customers in the Academia Government, Intellectual Property, and Life Sciences Healthcare end markets.
Continuously enriched, up-to-date knowledge assets, combining expert-curated data, structured taxonomies, and analytical models that transform complex information into actionable insights powered by a unique combination of AI-enabled software and human expertise.
We are home to industry specialists, consultants, and data scientists with deep subject- matter expertise and global experience.
Our highly curated, proprietary suite of branded information and insights solutions developed through our sourcing, aggregation, verification, translation, classification, and standardization processes combined with AI and other advanced technologies, positions us to deliver amplified intelligence in the age of AI.
REMOVED
The number of ordinary shares of the Company outstanding as of January 31, 2025, was 691,638,374 .
Market for Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 23 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 25 Item 7A.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 71 Item 9A.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 73 Item 13.
Unless otherwise indicated, dollar amounts throughout this annual report are presented in millions of dollars, except for per share amounts.
Our name, Clarivate, is derived from three powerful words: clarity, activate, and innovate.
We connect people and organizations to the intelligence they can trust to transform their perspective, their work, and our world.
Whether it s providing insights to advance an industry or accelerating the delivery of a critical drug, our vision at Clarivate is to fuel the world s greatest breakthroughs by harnessing the power of human ingenuity.
We offer enriched data, insights analytics, workflow solutions, and expert services to our customers in the Academia Government, Intellectual Property, and Life Sciences Healthcare end markets.